A comparative study of fused FDG PET/MRI, PET/CT, MRI, and CT imaging for assessing surrounding tissue invasion of advanced buccal squamous cell carcinoma

Clinical Nuclear Medicine

Volumn 36, Issue 7, 2011, Pages 518-525

  Huang, Shu Hua ^a,b   Chien, Chi Yen ^a,b   Lin, Wei Che ^a,b   Fang, Fu Min ^a,b   Wang, Pei Wen ^a   Lui, Chun Chung ^a,b   Huang, Yung Cheng ^a   Hung, Bor Tau ^a   Tu, Min Chien ^a   Chang, Chiung Chih ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

buccal mucosa; CT; FDG; MRI; PET; squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; IOVERSOL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CHEEK; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MANDIBLE; MASSETER MUSCLE; MASTICATORY MUSCLE; MAXILLA; MOUTH CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; RELIABILITY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DEMOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79958277677     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318217566f     Document Type: Article

References (28)

1. Chen YK, Huang HC, Lin LM, et al. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol. 1999;35:173-179. (Pubitemid 29113060)
2. Chien CY, Su CY, Chuang HC, et al. Angiopoietin-1 and -2 expression in recurrent squamous cell carcinoma of the oral cavity. J Surg Oncol. 2008; 97:273-277.
3. Liao CT, Wang HM, Ng SH, et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol. 2006;42:800-809.
4. Kowalski LP, Hashimoto I, Magrin J. End results of 114 extended "commando" operations for retromolar trigone carcinoma. Am J Surg. 1993;166: 374-379. (Pubitemid 24240991)
5. Antoniades K, Lazaridis N, Vahtsevanos K, et al. Treatment of squamous cell carcinoma of the anterior faucial pillar-retromolar trigone. Oral Oncol. 2003;39:680-686. (Pubitemid 36930115)
6. Liao CT, Chang JT, Wang HM, et al. Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories. Cancer. 2007;110:564-571. (Pubitemid 47106145)
7. Rumboldt Z, Day TA, Michel M. Imaging of oral cavity cancer. Oral Oncol. 2006;42:854-865. (Pubitemid 44428224)
8. Rasch C, Keus R, Pameijer FA, et al. The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1997;39:841-848. (Pubitemid 27486072)
9. Crecco M, Vidiri A, Angelone ML, et al. Retromolar trigone tumors: evaluation by magnetic resonance imaging and correlation with pathological data. Eur J Radiol. 1999;32:182-188.
10. Campbell RS, Baker E, Chippindale AJ, et al. MRI T staging of squamous cell carcinoma of the oral cavity: radiological-pathological correlation. Clin Radiol. 1995;50:533-540.
11. Yen TC, Chang JT, Ng SH, et al. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology. J Nucl Med. 2005;46:775-781.
12. Ng SH, Yen TC, Liao CT, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med. 2005;46:1136-1143.
13. Seitz O, Chambron-Pinho N, Middendorp M, et al. 18F-Fluorodeoxyglucose- PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen. Neuroradiology. 2009;51:677-686.
14. Van Baardwijk A, Baumert BG, Bosmans G, et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev. 2006;32:245-260. (Pubitemid 44502002)
15. Goerres GW, Schmid DT, Schuknecht B, et al. Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/ CT. Radiology. 2005;237:281-287. (Pubitemid 41346175)
16. Nahmias C, Lemmens C, Faul D, et al. Does reducing CT artifacts from dental implants influence the PET interpretation in PET/CT studies of oral cancer and head and neck cancer? J Nucl Med. 2008;49:1047-1052. (Pubitemid 351948011)
17. Ledezma CJ, Chen W, Sai V, et al. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience. Eur J Radiol. 2009;71: 242-248.
18. Pirotte BJ, Lubansu A, Massager N, et al. Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions. J Neurosurg Pediatr. 2010;5:479-485.
19. Berson AM, Stein NF, Riegel AC, et al. Variability of gross tumor volume delineation in head-and-neck cancer using PET/CT fusion, Part II: the impact of a contouring protocol. Med Dosim. 2009;34:30-35.
20. Baek CH, Chung MK, Son YI, et al. Tumor volume assessment by 18F-FDG PET/CT in patients with oral cavity cancer with dental artifacts on CT or MR images. J Nucl Med. 2008;49:1422-1428.
21. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932-945. (Pubitemid 46909922)
22. Babin E, Desmonts C, Hamon M, et al. PET/CT for assessing mandibular invasion by intraoral squamous cell carcinomas. Clin Otolaryngol. 2008;33: 47-51. (Pubitemid 351300168)
23. Yau YY, Samman N, Yeung RW. Positron emission tomography/computed tomography true fusion imaging in clinical head and neck oncology: early experience. J Oral Maxillofac Surg. 2005;63:479-486. (Pubitemid 40409844)
24. Seiboth L, Van Nostrand D, Wartofsky L, et al. Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer. Thyroid. 2008;18:103-111. (Pubitemid 351271523)
25. Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging. 2009;36(suppl 1):S113-S120.
26. Wang D, Schultz CJ, Jursinic PA, et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2006;65:143-151.
27. Chan SC, Ng SH, Chang JT, et al. Advantages and pitfalls of 18F-fluoro-2- deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2006;33:1032-1040. (Pubitemid 44218599)
28. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology. 2004;233:93-100. (Pubitemid 39280962)